Ljiljana Sjekloca
About Ljiljana Sjekloca
Ljiljana Sjekloca is a Research Fellow in Biochemistry and Biophysics at the National Heart Lung Blood Institute, specializing in structural biochemistry and bioinformatics. She has an extensive academic background, holding multiple doctorates and a Bachelor of Science, and has worked at various prestigious institutions across Europe and the United States.
Current Role at National Institutes of Health
Ljiljana Sjekloca serves as a Research Fellow in the Biochemistry and Biophysics Center of the National Heart Lung Blood Institute. She has held this position since 2016, contributing to research efforts in Bethesda, Maryland. Her work involves utilizing various structural biochemistry and bioinformatics techniques to explore protein and nucleic acid interactions, which are critical for understanding biological processes and developing therapeutic strategies.
Educational Background
Ljiljana Sjekloca has an extensive educational background in the sciences. She obtained her Bachelor of Science degree in Molecular Biology and Biochemistry from Università Degli Studi Di Trieste, studying from 1995 to 2001. She then pursued her Doctorate in Philosophy at the University of Vienna, completing her studies in 2005. Additionally, she earned another Doctorate in Philosophy from the Scuola Internazionale Superiore Di Studi Avanzati Di Trieste, where she focused on Philosophy and Genomics from 2001 to 2005.
Previous Research Experience
Prior to her current role, Ljiljana Sjekloca held several research positions. She worked as an MRC Career Development Post-doctoral Fellow at the Medical Research Council in London from 2006 to 2010. Following that, she was a Post-doctoral Associate at Karolinska Institutet in Stockholm from 2010 to 2012. She also served as a Post-doctoral Researcher at Harvard Medical School from 2012 to 2013. In 2014, she was a Marie S Curie Fellow at Area Science Park in Italy.
Research Focus and Collaborations
Ljiljana Sjekloca's research focuses on developing treatment, delay, and prevention strategies for human pathologies. She collaborates with professionals in the fields of structural biochemistry and bioinformatics to advance her research on protein and nucleic acid interactions. This collaborative approach enhances the understanding of molecular mechanisms and supports the development of innovative therapeutic solutions.